Aarti Drugs Promoter Group Shareholding Disclosure Under SEBI Takeover Code
Aarti Drugs Ltd has filed a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, detailing changes in shareholding by Dilesh Roadlines Pvt Ltd and other promoters/promoter group entities. The filing indicates a net decrease in the promoter group's shareholding. Specifically, Dilesh Roadlines Private Limited saw a reduction of 125,998 shares, and other promoters collectively sold 1,769,641 shares through market sales, while acquiring 370,156 shares via market purchases. The total promoter group shareholding decreased by 2,265,795 shares, resulting in a revised total holding of 49,681,228 shares, representing 54.03% of the total share capital. The total share capital of the company was adjusted due to a buyback of 665,000 shares.
Key Highlights
- Promoter group entities Dilesh Roadlines and others disclosed shareholding changes.
- Net reduction of 2,265,795 shares in promoter group holdings.
- Post-transaction, promoter group holds 54.03% of Aarti Drugs' equity.
- Changes are in compliance with SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- Company's total share capital adjusted due to a prior buyback.
Price Impact
More from AARTIDRUGS